Advertisement

Esophageal Cancer

  • Charlotte Dai Kubicky
  • Hans T. Chung
  • Marc B. Nash
Chapter

Abstract

Esophageal cancer accounts for 5% of all GI cancers. There are 16,470 new cases and 14,280 deaths from esophageal cancer each year in the US. It is the sixth leading cause of death from cancer worldwide. Incidence increases with age, peaks at sixth to seventh decade. Male:female = 3.5:1. African-American males:White males = 5:1. Most common in China, Iran, South Africa, India, and the former Soviet Union. Risk factors: tobacco, EtOH, nitrosamines, Tylosis (congenitalhyperkeratosis), Plummer Vinson syndrome, achalasia, GERD, and Barrett’s esophagus. Four regions of the esophagus: Cervical = cricoid cartilage to thoracicinlet (15–18 cm from the incisor). Upper thoracic = thoracicinlet to tracheal bifurcation (18–24 cm). Midthoracic = tracheal bifurcation to just above the GE junction (24–32 cm). Lower thoracic = GE junction (32–40 cm).

Keywords

Esophageal Cancer Gastric Cardia Transhiatal Esophagectomy Cervical Anastomosis Tracheal Bifurcation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgement

We thank Richard M. Krieg, for his valuable advice in the preparation of this chapter.

References

References

  1. Ajani JA, Winter K, Komaki R, et al. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinome of the esophagus: RTOG 0113. J Clin Oncol 2008;26:551-4556.Google Scholar
  2. al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 1997;15:277-284.Google Scholar
  3. Allum WH, Fogarty PJ, Stenning SP, et al. Long term results of the MRC OEO2 randomized trial of surgery with or without preoperative chemotherapy in resectable esophageal cancer. Proc ASCO GI 2008, abstr 9.Google Scholar
  4. Bates BA, Detterbeck FC, Bernard SA, et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996;14:156-163.PubMedGoogle Scholar
  5. Bedenne L, Michel P, Bouché O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007 Apr 1;25(10):1160-1168.Google Scholar
  6. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167.PubMedCrossRefGoogle Scholar
  7. Burmeister BH, Smithers BM, Gebski V, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005;6:659-668.Google Scholar
  8. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:1623-1627.Google Scholar
  9. Crehange G, Maingon P, Peignaux K, et al. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol. 2007 Nov 1;25(31):4895-4901.PubMedCrossRefGoogle Scholar
  10. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Eng J Med 2006;355(1):11-20.Google Scholar
  11. Downey RJ, Akhurst T, Ilson D, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003;21:428-432.PubMedCrossRefGoogle Scholar
  12. Gaspar LE, Winter K, Kocha WI, et al. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Cancer 2000;88:988-995.PubMedCrossRefGoogle Scholar
  13. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8(3):226-234.PubMedCrossRefGoogle Scholar
  14. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-1598.Google Scholar
  15. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-1984.PubMedCrossRefGoogle Scholar
  16. Kelson DP, Winter KA, Gunderson LL, et al. Long term results of RTOG Trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 2007;25:3719-3725.CrossRefGoogle Scholar
  17. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-1733.CrossRefGoogle Scholar
  18. Minsky BD. Cancer of the Esophagus. In: Textbook of Radiation Oncology. 2nd ed. Philadelphia: Saunders; 2004. pp. 811-824.Google Scholar
  19. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005;23:2310-2317.PubMedCrossRefGoogle Scholar
  20. Stahl M, Wilke H, Lehmann M et al. Long-term results of a phase III study investigating chemoradiation with and without surgery in locally advanced squamous cell carcinoma (LA-SCC) of the esophagus. J Clin Oncol 26: 2008 ASCO abstract 4530.Google Scholar
  21. Stahl M, Walz M, Stuschke M, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009;27:851-856.PubMedCrossRefGoogle Scholar
  22. Swisher S, Winters K, Komaki R, et al. A phase II study of a paclitaxel based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. Int J Radiat Oncol Biol Phys 2007;69(3):S106).Google Scholar
  23. Tepper J, Krasna M, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgey alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008;26:1086-1092.PubMedCrossRefGoogle Scholar
  24. Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001 Jan 15;19(2):305-313.PubMedGoogle Scholar
  25. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335: 462-467.PubMedCrossRefGoogle Scholar
  26. Wieder HA, Brucher BL, Zimmermann F, et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004;22:900-908.PubMedCrossRefGoogle Scholar

Further Reading

  1. Czito BG, DiNittis AS, Willett CG. Esophageal Cancer. In: Halperin EC, Perez CA, Brady LW, et al., editors. Principles and Practice of Radiation Oncology. 5th ed: Lippincott Williams & Wilkins; 2007. pp. 1132-1153.Google Scholar
  2. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-2252.Google Scholar
  3. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-1174.Google Scholar
  4. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Esophageal Cancer. Available at: http://www.nccn.org/professionals/physician_gls/PDF/esophageal.pdf. Accessed on May 04, 2009.

Copyright information

© Springer-Verlag New York 2010

Authors and Affiliations

  • Charlotte Dai Kubicky
    • 1
  • Hans T. Chung
    • 2
  • Marc B. Nash
    • 3
  1. 1.Radiation MedicineOregon Health and Science UniversityPortlandUSA
  2. 2.Radiation Oncology, Sunnybrook Odette Cancer CentreUniversity of TorontoTorontoCanada
  3. 3.Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations